University of Chicago, Section of Hematology/Oncology — Chicago, Illinois

University of Chicago, Section of Hematology/Oncology is a clinical research site located in Chicago, Illinois, United States.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Chicago, Section of Hematology/Oncology has participated in 2 clinical trials.

Therapeutic areas: Hormone-Refractory Prostate Cancer, Prostatic Neoplasms, Non-small Cell Lung Cancer.

Sponsors: Astellas Pharma Inc, OSI Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Chicago, Section of Hematology/Oncology?

University of Chicago, Section of Hematology/Oncology has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Chicago, Section of Hematology/Oncology conducted?

University of Chicago, Section of Hematology/Oncology has 2 clinical trials on record. Their work covers Hormone-Refractory Prostate Cancer, Prostatic Neoplasms, Non-small Cell Lung Cancer.

Is University of Chicago, Section of Hematology/Oncology accredited by Crixeo Health?

University of Chicago, Section of Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Chicago, Section of Hematology/Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.